Axsome Therapeutics, Inc.

NASDAQ:AXSM

87.25 (USD) • At close November 4, 2024
Bedrijfsnaam Axsome Therapeutics, Inc.
Symbool AXSM
Munteenheid USD
Prijs 87.25
Beurswaarde 4,188,017,450
Dividendpercentage 0%
52-weken bereik 55.02 - 98.4
Industrie Biotechnology
Sector Healthcare
CEO Dr. Herriot Tabuteau M.D.
Website https://www.axsome.com

An error occurred while fetching data.

Over Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical

Vergelijkbare Aandelen

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

96.35 USD

Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc.

ARQT

8.72 USD

NeoGenomics, Inc. logo

NeoGenomics, Inc.

NEO

14.14 USD

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

1.27 USD

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

56.82 USD

Veru Inc. logo

Veru Inc.

VERU

0.734 USD

MannKind Corporation logo

MannKind Corporation

MNKD

7.09 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)